Pfizer Settles Fee Dispute In $785M FCA Deal
Pfizer Inc. and a relator who blew the whistle on false claims have agreed to resolve their dispute over how much in attorneys' fees the company should pay after its $785...To view the full article, register now.
Already a subscriber? Click here to view full article